0.5835
-0.0675
(-10.37%)
At close: 4:00:03 PM EST
0.5622
-0.02
(-3.65%)
After hours: 5:04:54 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-376.3620
-480.9530
-1,248.5040
-1,735.0460
-254.7830
Financing Cash Flow
317
445
982.3330
1,857.6500
461.5050
End Cash Position
0.2530
28.4780
64.4310
330.6020
207.9980
Interest Paid Supplemental Data
56.8910
28.1280
81.5000
1.0640
--
Issuance of Capital Stock
50
55
--
--
200
Issuance of Debt
267
390
982.3330
527.6500
15
Repayment of Debt
--
--
--
--
-253.4990
Free Cash Flow
-376.3620
-480.9530
-1,248.5040
-1,735.0460
-254.7830
12/31/2020 - 12/3/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PLRZ Polyrizon Ltd.
0.7635
+0.39%
PTIX Protagenic Therapeutics, Inc.
0.2763
-9.41%
LPTX Leap Therapeutics, Inc.
0.4232
-8.66%
NBY NovaBay Pharmaceuticals, Inc.
0.5807
-4.02%
TSBX Turnstone Biologics Corp.
0.3550
-5.84%
ASBP Aspire Biopharma Holdings, Inc.
1.0100
-32.67%
RNXT RenovoRx, Inc.
0.9500
-4.99%
DRMA Dermata Therapeutics, Inc.
1.1400
0.00%
ABP Abpro Holdings, Inc.
0.5100
-16.76%
CTNM Contineum Therapeutics, Inc.
6.59
-6.39%